[00:00:00] Carl Lanore: [00:00:00] Welcome back to another episode of super human radio. Today we're doing a long awaited pep talk and a with dr Elizabeth , your earth. And just, just a second, I want to kind of set the table. Um, so everybody wants to be out there today and be a peptide expert. And a, the trend is to do shows with lots of peptide information.

[00:00:27] So you can show that, Oh, you just know everything about peptides. This is a very competitive, uh, area right now today. But it's an area that I have the great luxury of having. Uh, been at the tip of the spear since around 2006 when we talked about things like, uh, uh, G Charpie six, and of course, growth hormone and IGF one.

[00:00:58] And so [00:01:00] I want to do things a little different with the pep pep talk. I could go through the, the dictionary of peptides and name the names and say it's good for this, it's good for that. And that, that seems to be the trend right now. But I like to do deep dives because quite often when you do some deep dives, you not only learn a lot more, but you realize that you can help a lot more people with this.

[00:01:21] And today's peptide is, is one of those because it shows the ability to truly treat, not mask the symptoms, but truly treat, uh, neuropathy, neuropathies of all types. Whether they be, uh, the types of, uh, neuropathy that cause fibromyalgia patients to feel that, that life derailing pain or diabetics who have peripheral neuropathy and their feet hurt all the time to people who announced starting to lose motor [00:02:00] ability because the neuropathy is getting so bad.

[00:02:03] Um. Today's peptide may represent the first and only, uh, therapy that fixes the problem. And now let's get on with it. Dr Elizabeth, yours. How are you doing? Betsy,

[00:02:19] Dr. Elizabeth Yurth, MD: [00:02:19] I'm great. Carl, thank you so much for having me.

[00:02:21] Carl Lanore: [00:02:21] This is a really exciting peptide, right? There's lots of sexy peptide. IGF one builds muscle and you know, uh, uh, AOD nine six Oh four may make you lose weight.

[00:02:31] I know why people have no success with it, but that comes from my bodybuilding years. But you know, we have all these sexy peptides and then all of a sudden one comes along that actually addresses a major area of chronic illness in our population. And this is it.

[00:02:47] Dr. Elizabeth Yurth, MD: [00:02:47] Yeah, exactly. I love the way you started this podcast because you know, I can really get on any night now and I try and stay abreast of the podcasts that are being put out there and try and see what all the information that's being spread, some of which is good and some [00:03:00] of which is not.

[00:03:01] But everybody is getting on there. Now, I'm getting on this bandwagon of peptides and you know, and there's podcast after podcast is just through, you know, vomited up 25 different peptides and people are like, Oh, I guess I need that and that and that and that. And nobody is really getting to the heart of, you know, why do we really want these in our lives?

[00:03:18] Because ultimately, you know. It's not simply, I love that we can build muscle and we can have harder erections, and you can do all of the stuff. But ultimately what my passion is as a physician, and you know, and I think yours is actually to sort of change the world for people who, whose lives are kind of debilitated.

[00:03:36] And this is a peptide that's going to allow us to do that. It's gonna allow us to treat people right. And not just be more debilitated. I mean, you and I were talking about that we both have some peripheral neuropathy issues and you know, tons of people were just walking right by when I guess it is what it is.

[00:03:49] So my feet are a little more numb and no reason for it. We're healthy. And, and we've just said that is the way it is. And so I think there are so many people out there who can be helped by this and for us to [00:04:00] deep dive in us and really show people what we can do. That's where the future is going to be.

[00:04:04] It's not going to be on this, you know, saying, Oh, everybody needs growth hormone and

[00:04:08] Carl Lanore: [00:04:08] I want more. I want to be Tanner. I want and mulatto tend to, I want to be 10 or, you know, so

[00:04:14] Dr. Elizabeth Yurth, MD: [00:04:14] we all want that, but we really need to focus on where these countries are going to take us and our ability to actually make people's lives so much

[00:04:21] Carl Lanore: [00:04:21] better.

[00:04:22] So the estimates of, uh, people in our population that suffer from what is classified specifically as peripheral neuropathy runs between seven and 12% depending on who you talk to. Um, the number of women. Specifically, because this strikes women more often, that suffer from fibromyalgia goes anywhere from 40 a four to 21% depending on who you're looking at.

[00:04:51] Uh, and so the, the vast number of these disorders effected by. [00:05:00] Nerve degradation really either go unreported, undiagnosed, or just attributed to age. Oh, well, yeah. You know, my heart rhythms changing. Everybody's got my mitral valve prolapse today. Everybody's got PVCs. Everybody's got a Rhythmia is a idiopathic  everybody, you know, and you know what?

[00:05:24] I'm a schmuck. I mean, you know. I'm I, I'm just the guy who was fascinated by all this stuff. I don't understand why more people in the medical community aren't looking and going, why the F is this? Why does everybody have sleep apnea? Why does it, and I think sleep apnea is tied to this. I'm going to tell you as we get into this, uh, why aren't people going instead of just trying to cure this, why don't we try to find a way to plug the hole

[00:05:54] Dr. Elizabeth Yurth, MD: [00:05:54] to believe that needy. Yeah. Chronic pain is a whole lot bigger problem. The, just [00:06:00] the group of peripheral neuropathy, there's all types of chronic pain. We sort of think of chronic back pain. I, you know, I specialize in spine and in my orthopedic practice, and you'll call it back pain is, it's the bane of our existence and, and people have chronics I had a pain and things like that.

[00:06:15] Well. I know I love all of that into a neuropathic type of pain, that chronic pain that we can't get a handle on, which is why we treat it with things like ketamine or, um, you know, or things that are working like Gabapentin. So we're working on, we're trying to work on, we know this is some kind of neurologic disorder, so copy is not simply just that, Oh, you hurt your back.

[00:06:37] There is a, there's a lot of would degenerative this. Why does some of them have pain? Some not. I think this is a neuroinflammation problem. That's exactly what this peptide is geared to do. So peripheral neuropathy may be, you know, one or two out of every 10 people, chronic pain affects as many as 40% of the population.

[00:06:54] Carl Lanore: [00:06:54] Well, and, and, and I would argue that 90% of the population who's over 40 is [00:07:00] starting to suffer from degradation. Of the nervous system. And you know, anybody who's, I'm 61 years old, so I remember cars that had wiring harnesses that were serviceable, like my, my, my, uh, triumph GT six. It had this, this silly little problem if I turned right, really, while I was going really, really fast, something shifted and leaned against the wire that had worn out and the dielectric failure caused a short.

[00:07:32] And my lights would go on and off and I just lived with it, but our bodies start to display some of these same things. If you notice that you feel a buzzing in your legs in your hands. Uh, people complain about buzzing. If you have subjective tremor, you say to your doctor, I'm shaking, but, and your doctor holds, your hands goes, you're not shaking.

[00:07:56] That's subjective tremor. If you start getting any of these spooky [00:08:00] little things, your wire harness and your body is starting to wear out, it's started. It's starting to malfunction. And that may sound. Well, not such a big deal because, Oh, I can live with that. But that also is going to screw up the way your kidneys function, your heart functions, your brain functions.

[00:08:18] The wiring harness in our body is what facilitates every effing thing we do. Whether we pay attention to it or we don't.

[00:08:29] Dr. Elizabeth Yurth, MD: [00:08:29] Exactly. So you're all kind of goes down to. It's special to have this, this peptide air two 90 works is that when we have an injury and we're getting chronically injured, right?

[00:08:41] There's little injuries going on all day long. You touch something sharp where you burned yourself, where you overworked the gym, but, but our body has an inflammatory process that's designed to be there to help save us right? To help heal the injury, and that inflammatory process should be accelerated.

[00:08:57] And then DAP and back down [00:09:00] where this probably. Emanates from is the dampening down doesn't occur properly. So instead of inflammation coming up and we see this elevation of interleukin 10 and Truman necrosis factor alpha and all these things, they get elevated instead of, it'll contend and things coming down to bring them back down.

[00:09:19] They just stay elevated. And that cascade, that inflammatory cascade now feeds off into other cells, and we think that's what begins his whole process of neural damage. It's, you know, this real activation. It's this inflammatory cascade at the nerve level. The now doesn't stop. And once that just keeps going and keeps going and keeps going.

[00:09:39] Now you're suffering ongoing nerve damage and ongoing chronic pain and numbness and weakness and everything that we just discussed. And so what the air tonight is doing is it's coming in to shut down that inflammatory

[00:09:53] Carl Lanore: [00:09:53] primer and cause it to resolve. Exactly. It's actually, so we've talked about, resolves on the show over and over [00:10:00] again because there are some aspects of Omega three fatty acids that, uh, so, so.

[00:10:05] There's two ways that people address pain. Three. One is to confuse the brain. And not think it feels pain anymore. And these kind of drugs tend to be the most harmful Gabapentin things like this Cymbalta. These drugs are horrible because effectively what the, so, so if you told me your hand hurt and I came over and stomped on your foot, your hand wouldn't hurt anymore because your focus would be the pain in your foot.

[00:10:30] So with these. Drugs do is they just kind of disassociate pain entirely from where it's coming from, but you have this general sense of malaise. You just don't feel good, horrible, horrible drugs. The other thing is. Like an sets, just shut off inflammation. Just shut it off. Corticosteroids just shut off inflammation.

[00:10:51] This is not good

[00:10:54] Dr. Elizabeth Yurth, MD: [00:10:54] there to heal us.

[00:10:55] Carl Lanore: [00:10:55] Yes. And the third class, our resolve , which we know a mega threes [00:11:00] tend to fall into some Kirkin Lloyds fall into, well, this peptide appears to be a super powerful resolve and because it, uh, it activates these league that, uh, trigger. The actual healing process,

[00:11:16] Dr. Elizabeth Yurth, MD: [00:11:16] right? Yeah, it's exactly right.

[00:11:19] So, you know, it's, it's, it's basically an analog version of wheat, but unlike earth or freedom, which most of your athletes who are watching your show are familiar with, it's a different forms as a tissue  it's a presence, which is not having the cardiovascular effects, the kidney affects. It's working on the tissue.

[00:11:36] It's probably what happens is women injury. We have an upregulation of this earth recruiting that actually activates this innate repair receptor. And that's a really, you know, that's an important part of this process of a VA to dampen the inflammatory cascade. So what's so, so when it's tissues damaged, they're worth repeating is released, and we get the care credit influences.

[00:11:56] So what we're doing with the era two 90, which is basically, [00:12:00] it's kind of a, um. A three dimensional model of this fragment of Bertha predone, that that basically activates this innate repair receptor. And we'd be in this whole repair process, right. And you know, and stop the inflammatory process is causing the ongoing degradation of nerve cells.

[00:12:16] So you're right, it's curing the problem. It's stopping it in its tracks, allowing your body to heal.

[00:12:23] Carl Lanore: [00:12:23] So let's talk a little bit about the results of some of the research that was done over at the Cleveland clinic by, uh, Dr. Daniel, uh, Collier, uh, to give him the appropriate, uh, so these are these, these are from the slide presentation.

[00:12:37] He did, uh, after doing, um, so the first thing that they showed, we just talked about the different, different approaches to treating a small fiber. Uh, damage. Hold on a second. I'm going to get good at this. I promise this. This one here actually showed in a rodent and then we're going to, we have human as well.

[00:13:00] [00:12:59] This one here actually showed in a rodent model that the, uh, the dark green is the nerve injury. And on the right side, after the submit, a tide was applied. And that's the name of the, the, the peptide. You can see how much of the nerve injury went away. That whole area got nice and dark. And this was one of the slides that led to, uh, their desire to do the de Saara study.

[00:13:28] And let's, so let's talk about that study. Let's talk about dosing and let's talk about what the, uh, what the outcome was.

[00:13:35] Dr. Elizabeth Yurth, MD: [00:13:35] So, so this was. You know, the best study we have, which is a double plot, blind placebo controlled study, you know, to look at at this drug and sort of the phase one, Scott. So let's start, I think people don't know this, you know, so era two 90 is actually by coming to Ehrenfeld pharmaceuticals was proposed as a drug.

[00:13:54] It, as I bent aside, you know, a while ago, and it has just been sort of stuck up in the whole [00:14:00] FDA process. So like a lot of things were just. Yo sitting around for waiting for drugs. It's already been proven safe. It's already been proven effective and yet is stuck up in, you know, and people can can get it.

[00:14:11] I think the study population was 60 patients. Yes,

[00:14:15] Carl Lanore: [00:14:15] yes, yes.  and one got a placebo. One got one milligram a day for 28 days. The other one got four milligrams a day for 28 days in eight day. At the 28 days they showed here. I've got some good slides here. I'm going to, I'm trying to make this flow nicely here.

[00:14:34] So this, this, uh, this particular slide showed the actual, uh, relevance and its ability to increase new nerve fibers to grow.

[00:14:45] Dr. Elizabeth Yurth, MD: [00:14:45] Right.

[00:14:46] Carl Lanore: [00:14:46] Uh, the, the one in the left, I don't know if you can see it clearly, uh, Betsy, but that was the one that was done on corneal. The one on the right was done on tissue in general skin.

[00:14:58] I was skin tissue. [00:15:00] And you can see the, it was much more dramatic in the skin tissue, uh, than it was in the corneal tissue. But both of them had significant

[00:15:09] Dr. Elizabeth Yurth, MD: [00:15:09] changes. I don't know if you have a slide from his lecture where he showed the. The corneal tissue and you can see all the new nerve fibers.

[00:15:17] Carl Lanore: [00:15:17] Yeah, I have it.

[00:15:18] Hold on, hold on. I get it. I actually, we didn't plan this everybody, I just kind of did this at the last minute, so it's going to be a little awkward, but yeah, this is it right here.

[00:15:27] Dr. Elizabeth Yurth, MD: [00:15:27] Yeah. So, so, right, so this is great. This is a corneal nerve fibers, and on the left side is the normal tissue. On the right is after, is, you know, is a damaged corneal nerve.

[00:15:37] Fiber CC is, there's no fibers left. These are all these little tiny damaged nerve viruses. So what happens, this is a cornea, but this happens in your fingers. It happens in your toes. It's all your peripheral tissues. Those little tiny, tiny nerve fibers just are killed up. I think these were in sarcoidosis patients.

[00:15:52] But you know, this happens at a lot of different diseases. It happens in diabetic retinopathy. Um, and so, and then on the right is after they treated these patients [00:16:00] with the arrow two 90, and, uh, after 28 day course. And you can see, not normal, but significantly mean, you know.

[00:16:06] Carl Lanore: [00:16:06] Yeah. You could see what you basically see is you see new nerve sprouting, all

[00:16:11] Dr. Elizabeth Yurth, MD: [00:16:11] new nerves that are broken

[00:16:13] Carl Lanore: [00:16:13] and, and, and, and the skin was even more, uh, impressive because the skin, uh, tissue that was used.

[00:16:23] So an even denser accumulation of new nerves. So this is, you know, it two different types of tissue. One of them corneal is very hard to get nerves to regenerate, and that's why they use that. Because if you could do it in that, and sure enough in the skin, it was even better was even though

[00:16:43] Dr. Elizabeth Yurth, MD: [00:16:43] this is amazing, we don't have anything.

[00:16:45] You know, you know our material right now that would do this. We, you know, we can, we can give you all those drugs that you pointed out and say, well, I hope this helps with your pain. And it works about 30% of people. So as far as people that helps their pain, it's doing nothing to fix their problem. So [00:17:00] you already have a drug that's not only, I mean, this is great, but also correlated to reduction in pain.

[00:17:06] Carl Lanore: [00:17:06] And they showed that they actually showed side by side the one. For an eight milligram a day to, for 28 day patients and their pain scores were more dramatic. In fact, they did. I hope I put it up here. Hold on a second. Let me just see if I have this slide. Um, they did a six day walking. I may not have got it in here.

[00:17:30] Oh yes. So, so they did a six minute walk test. And these are people who couldn't walk any longer. Of course, their peripheral neuropathy was so bad. Now it was causing motor challenges. And I know what this feels like because I have some of that, um, awkwardness sometimes I feel, and I know what it's like they, they showed they, the people on the left improve their six minute [00:18:00] walk test and had no pain.

[00:18:04] Or little pain. One woman stepped up and said that she hasn't been able to go to the mall in like a year or two because she can't walk and now she's going to the mall again. Right? Like that's how fast that was just in 28 days.

[00:18:19] Dr. Elizabeth Yurth, MD: [00:18:19] Well, they actually started those improvement within three days and she, by the third day of gene that people report that they were starting to feel the improvement.

[00:18:25] So, you know, really pretty rapidly to back pain or improvement. Um, correlated over time to more functional improvement. And then we'll regrowth of the nerve fibers over a 28 day cycle. It appeared that even after the 20th, they cycle, a fair number of patients continued to maintain. Obviously there's some disease process that's continuing to cause damage.

[00:18:44] So let's say there is some reason you have the peripheral Apia, you've got to treat that at the same time, right? So we regrow the nerve fibers, but then if, if there's, there's some. Insulin still being.

[00:18:54] Carl Lanore: [00:18:54] Yes, and I want to, I want to, I want to put this up. I want to put this up for that reason because this is an important [00:19:00] distinction distinction.

[00:19:01] So what they looked at, uh, based on the dose one, four or eight milligrams for 28 days, they saw dramatic changes. As you could see by the upswing, the, the placebo was the red line. They, they actually got worse over the, over the period of time. They, they, the other groups all improve both their pain and the density of new nerve growth that seemed to disappear around 40 56 days.

[00:19:37] And that's why it drops back down here because after the 28 days, they continued to follow these patients. And a lot of it that a lot of the benefits seem to be going away. And the good doctor said, maybe they just need, excuse me, longer therapy. And I said to myself, no, you haven't done anything to eliminate [00:20:00] the insult that causes.

[00:20:01] So I mean it, look, if your house is on fire and you buy new furniture and put it in, it's going to burn up just like the other furniture did

[00:20:07] Dr. Elizabeth Yurth, MD: [00:20:07] right.

[00:20:11] For instance, you know, chemotherapy induced, you know that the insult was a while ago. You've already taken away and now they're just living with the consequences of it. So now it has something to offer those people who had some bad disease or cancer damage the nerve endings. And we have something that said, Hey, we can give you back your life.

[00:20:28] It is absolutely amazing that you know, and that no one even knows about this peptide, that you know that  studies were not really, if you've got on your blogs about neuropathic pain, people were. Talking about it, but you know, but the fact that it's just no doctor, you had mentioned it to you knows anything about it is remarkable to me and we need something that's so incredibly important to us.

[00:20:51] Carl Lanore: [00:20:51] Yeah. I mean, do you think, is that just because, and I don't often defend doctors, but I have so many doctors that I love and I'm friends [00:21:00] with that I almost feel compelled to say, well, a lot of them may be, you know, it's part of it, the whole standard of care cage that doctors live in. You think.

[00:21:11] Dr. Elizabeth Yurth, MD: [00:21:11] Aye. I would like to defend doctors.

[00:21:14] I am one, but, but I think I, I think that is a little bit of it, a little bit of as a, is that doctors tend to be very set in their ways and it's very, very hard to change. Most physicians, there's a few few doctors and you'll see them in the young people you talked to and unfortunately appreciate your, you're preaching to the choir that, you know, I work with very conservative partners in my orthopedic practice who don't want to hear any of this stuff.

[00:21:36] They don't take the time to read new things or learn new things. What they're doing is working. You know, they're replacing, they have, they're doing this, they're throwing up their hands to peripheral neuropathy and saying, well, there's nothing you can do. And I, you know, part of it is that you can't do this kind of medicine in 10 minutes and 15 minute appointments.

[00:21:52] Part of it is you have to spend a lot of time learning. You have spend a lot of time reading. I mean, I felt I don't sleep, you know, I read all night long and [00:22:00] you know, and so I think that that's, medicine is so incredibly slow to change. Yeah. You know, if you look at what we're doing now, it has very little difference to what we were doing 20 years ago.

[00:22:10] And so I would like to not folk doctors and say it's all the system, but I think I'm going to tell doctors a little bit, and the doctors need to go out and I need to meet and they need to learn and they need to listen to you and they need to, they need to open their minds.

[00:22:22] Carl Lanore: [00:22:22] I want, I want to take our first commercial break, and when we come back, I want to start to talk about the nature of.

[00:22:30] Degradation of the nervous system and some of the other things that may be tied to that. People don't think about, uh, when they hear people to old peripheral neuralgia. I don't, I don't have that. I don't have that, but I want to get into that because the fibromyalgia one is a big one.

[00:22:46] Dr. Elizabeth Yurth, MD: [00:22:46] That's huge.

[00:22:47] Carl Lanore: [00:22:47] It strikes almost exclusively women and, and generally as a rule,

[00:22:54] Dr. Elizabeth Yurth, MD: [00:22:54] what's that?

[00:22:55] Carl Lanore: [00:22:55] And also the crazy. Yes, and generally when it's just women, [00:23:00] doctors dismiss them and it's a horrible place to be because you want to feel better. You just want to be back to normal and they're looking at you like, Oh God, it's her again. Like, Oh, what can I give her today to make her go away? I mean, really, that's what it comes down to.

[00:23:14] So let's take a quick commercial break. We'll be right back with more of the pep talk stage. This is the superhuman channel where we use oxygen for the power of good.

[00:23:28] Welcome back. I forgot to say the date. Today's January 17th, 2020 for those of you listening to the show a hundred years from now and going, wow, these people really knew what they were talking about. Uh, I gotta read something real quick. Pay a bill. Dr seeds. Ashwagandha is an adaptogenic herb that has been held in high regard for millennia because of its use in medicine.

[00:23:54] Ashwagandha also helps in the gym boosting muscle mass and reducing inflammation. Is [00:24:00] that inflammation again? Uh, in men, ashwagandha has been shown to increase male fertility and sexual function in women. Ashwagandha has been shown to improve arousal. Dr seeds is. Available in 1200 milligram doses for women, 1,950 milligram doses.

[00:24:18] For men, that's a big deal because all the ashwagandha on the market is in 300 400 or 600 milligrams. It's like it's under dosed. People take one cap, they go, this doesn't work. You can get 15% off of This email address is being protected from spambots. You need JavaScript enabled to view it. today by using the code a. S H. a. Also check Amazon. Uh, as always, feel free to say it however it comes naturally.

[00:24:45] Ah, I wasn't supposed to read that part. No, but they're, they're great. I love dr seeds and I love the people over at, uh, dr  dot com and they make great products that fill important gaps. All right, so let's talk [00:25:00] about this fibromyalgia. Let's start there because that's huge. Um. This, this is an ideal. Have you ever fibromyalgia patient and you've tried, you know, low dose naltrexone and you've tried this, you've tried that, and they, you know, they're not getting any better.

[00:25:18] They've life sucks. They have to, can't work anymore. They can't be mothers anymore. Wouldn't it be logical to give this a shot? Like they'd probably notice differences pretty quickly? I think

[00:25:29] Dr. Elizabeth Yurth, MD: [00:25:29] so. I can pretty rapidly, I have not yet tried this in my fibromyalgia patients. I think that if you look at our Mallory, even some of the muscle biopsy stays had been done in fibromyalgia.

[00:25:39] It probably is a type of small fiber neuropathy that creates an Allegheny or an abnormal pain response, right? We know that that neuropathy is not just numbness and tingling and all the things, but if pain, and sometimes it's a very horrible short pants and as it's really just this, you know, this weird.

[00:25:56] You know, abnormal pain sensation. So, you know, if I'm out the patients, you've, [00:26:00] you've touched them a little bit and it hurts, you know,

[00:26:02] Carl Lanore: [00:26:02] hyperalgesia, hyperalgesia. It's horrible. Yeah,

[00:26:06] Dr. Elizabeth Yurth, MD: [00:26:06] you're right. And they're patients. We hate to see as doctors, you know, the rheumatologists send it to me. I send to somebody else.

[00:26:12] And because you're like, I don't know what else to do.

[00:26:14] Carl Lanore: [00:26:14] You know, you could try because the symptoms, the symptoms. Are symptoms of many other things. It's like, and there's no, there's no blood test for fibromyalgia, but here I just put up a study that says, the title of this study is, I'm trying to open it so I can read it.

[00:26:31] Fibromyalgia and small fiber neuropathy. The plot thickens and basically this study comes away going that fibromyalgia patients suffer from small fiber degradation. Yeah, so treating it like a small fiber disorder makes more sense than treating it like this. Morphous touchy feely. I don't know what I'm doing, doctor.

[00:26:55] Dr. Elizabeth Yurth, MD: [00:26:55] Yeah. And the precedents and all those types of things was, yeah. More [00:27:00] crazy and more dysfunctional. Um, and so, yeah. Here's something that. Ultimately, you know me take care of the problem and be somewhat of a cure cause it's going to repair those neurons and we don't know. Maybe we'll have to repeat the course maybe, but you need a six week course of a drug that has no real bad side effects that we can discern.

[00:27:18] Every drug that we put those patients on has bad side effects. A lot of 'em are bad for your brain, and so we need to earlier dementias and things like that.

[00:27:27] Carl Lanore: [00:27:27] Oh my God. It's like, so I think one of the side effects of Cymbalta is that it can cause movement disorders. I'm like, wait a minute. You know, I feel terrible.

[00:27:36] I don't want to end up with a Parkinson's like disease from taking my medication. Right.

[00:27:41] Dr. Elizabeth Yurth, MD: [00:27:41] Oh yeah. Right. You know, and, and you know, and at worst on chronic opioid therapies for a lot of them, but this is a dysfunctional disease where a lot of women, I see being a female in orthopedics. I see a lot of these women because nobody knows what to do with that.

[00:27:55] Like, well, go see dr  because she's a woman. Maybe she'll understand you and you know, and, and I kind of, [00:28:00] I worked them up. I try and figure it out, but now I was have something to really offer them, I think in wanting to do the study. But I think it'll really be, be amazing for treating those people and even on a lower grade, because a lot of people who have, you know, they're not Frank.

[00:28:14] I have all the exact same as a fibromyalgia, but. We just had this just chronic achy pain all the time,

[00:28:20] Carl Lanore: [00:28:20] right? Yes. So evidence that your nervous system is starting to wear out, like we talked about with the car, right. And obviously changes in heart rhythm just out of the blue, right? All of a sudden, um, you notice that your heartbeat much faster doing little things.

[00:28:36] I mean, you could be out of shape. I'm talking about if you're in shape, cha, you've been diagnosed with the AFib. Not related to a heart valve problem, but even if you have heart valve problems, cause remember everything malfunctions when the electricity that's feeding it starts to go away. I mean, they have brownouts where the whole city is still kind of trying to work, but things aren't working [00:29:00] well.

[00:29:00] Your body can have brownouts and those brownouts are caused because the, uh, the innovation of the nerves driving those things. Are getting weaker and weaker and weaker. And I just want to put this one out there. Dr. York was telling me if this logic makes sense. None of you have Frank GERD, like, you know, when you drink coffee, you get heartburn.

[00:29:24] But those out there who have what is called a silent GERD, and this is usually, uh, the flavor and your taste in your mouth changes a little bit, but it's nothing, nothing to worry about, you know? Okay. And then. You get scoped one day a doctor says, well, you've got barrettes syndrome. Do you suffer from heartburn or no, I don't.

[00:29:44] I never have heartburn. That is the innovation to the esophageal sphincter is, is just not staying closed as tight as it used to be. The muscles are getting a little weak and that little pucker just isn't there [00:30:00] anymore and just a little bit here and there just seeps out of your gut and all of a sudden you have a disorder.

[00:30:05] What do you think. I

[00:30:07] Dr. Elizabeth Yurth, MD: [00:30:07] think it certainly makes sense. I think you probably could start putting almost every disease down into a neuroinflammatory piece down

[00:30:14] Carl Lanore: [00:30:14] that's aging. The core of the core of the sick aging phenotype is the nervous system starts to break down.

[00:30:24] Dr. Elizabeth Yurth, MD: [00:30:24] Right? But look to your call your patients.

[00:30:26] How many people do you know, and I'm sure this, a lot of your listeners who are these high level athletes and have had this, they have a disc herniation and they. They have sciatica and they have surgery and they take away the discrimination and they still have horrible sciatica, and it's a horrible bathroom.

[00:30:40] Well, why is that? It's because when that is created, it created this horrible neuro neuroinflammatory process. When I removed that disc, it didn't get rid of the neuroinflammatory process necessarily. Right. And so now this ongoing cascade, and they still have this chronic pain, you know. And so if you can shut that [00:31:00] down an early phase, you're number one.

[00:31:02] Probably a lot of women need the surgery because you could probably shut down the neuroinflammation at stage where the nerve doesn't start getting so traumatized. And number two, I think we can treat a lot of those people. So I'm really excited from my, my practice, you know, in orthopedics to to be able to say, well, all of these people I have, well, he's really chronic.

[00:31:18] You don't lay pain and things like that. Post is fine. Injury that, you know, we try to put in steroids around the nerve. Well, what are steroids doing there? They're temporarily blocking an inflammatory process, but that's not doing anything to change that process and heal the nerve. So I think we're going to see this as time goes on because we have very limited studies on it yet.

[00:31:37] We need to start using, you know, in all these different populations of people. You know, with your  patients, your peripheral neuropathy patients, your, your Sadeka patients, your people who have had thoracic outlet syndrome there. There's all these different things that, that I think we're going to be able to find that we pull this drug into.

[00:31:55] And, and even if we were talking about sort of this whole neuroinflammatory well, let's trust been shown. [00:32:00] I mentioned this briefly when you and I talked to help that bullet control.

[00:32:04] Carl Lanore: [00:32:04] So when we saw a

[00:32:06] Dr. Elizabeth Yurth, MD: [00:32:06] point drop and he will put anyone see and people after 28 days we were on this medication. So why is that?

[00:32:11] Why is the drug that's, you know, that's, that's acting like a peripheral was a prednin and worked on an their repair receptor helping diabetes and helping cholesterol. It's lowering LDL, raising HDL. So heal your why is that?

[00:32:26] Carl Lanore: [00:32:26] You know what, exactly? I have a feeling. I have a theory.

[00:32:28] Dr. Elizabeth Yurth, MD: [00:32:28] Yeah. And let me carry his car.

[00:32:31] Carl Lanore: [00:32:31] It's the electrical system to the liver. It's the electrical system too. You know, the liver depends on energy to do its job, and the nervous system is doing, giving the impulses for the liver to do its job. The pancreas is being fed by the nervous system when it's supposed to squirt out insulin. You know?

[00:32:49] I think that the, and this kind of speaks to what. My, I think my real value of this isn't just rescuing people who are living with [00:33:00] horrible pain in their lives and, and lack of motor skills because their doctor said, ah, you're just getting old. The more insidious side of this is that. When Oregon start receiving Brown outs and they start malfunctioning.

[00:33:18] So if you, if you are re collateralizing the nervous system you because of this one thing over here, but the entire nervous system is getting a rebuild. Everything's going to start working good again, including your brain, your eyes, everything.

[00:33:33] Dr. Elizabeth Yurth, MD: [00:33:33] Exactly. I think you're right. I think, you know, if you think about it, you could probably bring everything down to, if you can correct the nervous system.

[00:33:39] If you could go into a little nerves working, can you get the organs functioning better? You'd get muscles function better because everything is innervated by nerves. Right? And that our tissues, none of them were independent of our brains. Any the nerve message down there. And you know. No degradation or you know, I was talking about I have bad remote's syndrome, I get cold, my hands get blue.

[00:33:58] They get numb. And [00:34:00] why is that? Well, it's because those little peripheral nerves are not working well and will also, my body is that going on. Cause we know people with renos have higher risk of cardiovascular disease. Right? And so you know, that process is not, you know, whenever you have somebody who has a bad symptom, when you have numb feet, you can say, Oh, it's your numb feet.

[00:34:17] Where else is your body being affected? That might be more critical.

[00:34:20] Carl Lanore: [00:34:20] Oh my God. The heart. I mean, he looks on the heart.

[00:34:24] Dr. Elizabeth Yurth, MD: [00:34:24] Um, you know, so this whole, this whole process where we, where we sort of targeted on, you know, okay. Yeah, there's obviously neuro inflammatory processes done, damage these portfolios. Okay.

[00:34:34] Your feet are numb if you can live with numb feet, but likely there's just other things going on that you can't, you're not, you're not seeing the results of yet. So I think we need to be more aggressive at treating these people. Not just to help with the pain, but overall healthier.

[00:34:49] Carl Lanore: [00:34:49] I, I've said on this show a half a dozen times or more that the nervous system is the Canary in the mind.

[00:34:56] The nervous system is the most sensitive, the most delicate [00:35:00] and the most important. Really, when you think about it, right? Cause you can say the heart is the most important, but it depends on the nervous system to beat. And you can say the brain is the most important. Yeah. But it depends on the nervous system to work.

[00:35:12] So I've always said. When you start developing neurological issues, this is just evidence that something is really going wrong. That tissue gets attacked first, and that's your early warning system to stop doing what you're doing. But most people don't know what's doing it in the first place.

[00:35:32] Dr. Elizabeth Yurth, MD: [00:35:32] Right?

[00:35:32] Carl Lanore: [00:35:32] So did this, I think that this, this peptide has some of the most potential pleiotropic benefits, not just from.

[00:35:42] Managing pain and, and fixing the nervous system. But literally, and I hate to say this, cause as soon as I say, Oh, it's, but have a more anti-aging effect on you than any six peptides you're taking right now. You know,

[00:35:56] Dr. Elizabeth Yurth, MD: [00:35:56] you showed that that walking test right there are [00:36:00] one of the things that's predictive of your age, how well your age

[00:36:03] Carl Lanore: [00:36:03] and how long you're going to live.

[00:36:05] Dr. Elizabeth Yurth, MD: [00:36:05] Walking test, how fast you walk, how long are you going to live, and you can do Metro longevity based on somebody doing a speed walk test and you just show that the peptide actually improved speed walk. So. You're right. Are we actually going to, you know, if we're saying that's a really good correlation, you just changed

[00:36:22] Carl Lanore: [00:36:22] that.

[00:36:22] I, I'm thinking about this peptide in my nipples are hard right now. I'm not kidding. I want this peptide. I want to start taking it right away because I do have some of these age related degradations and I think that I can not only reverse them, but I think that I can actually. I think I could make my body more youthful.

[00:36:42] So what would would the four milligram a day be a good place since it's kind of a

[00:36:48] Dr. Elizabeth Yurth, MD: [00:36:48] sub Q injections in dangerous B, if you looked at that little graph, anal graphs did not work as well as for some more is not better than this or four milligrams a day. We've, we've been doing it for about a three day course.

[00:37:00] [00:37:00] Uh, you know, right now that the stakes are pan out, that a 30 day course is going to, to, you know, a lot of the power that's going to do a lot of rebuilding. I'm not sure, you know, I don't know that we know like a lot of peptides. Exactly. So will you do another retreatment at, you know, at three months or six months?

[00:37:16] I think that's going to be a little trial and error for us to figure out. Um, it's a very good peptide and TaylorMade is the only people making it right now that I know of, unless you can get, I guess in some of the trials stable, it's identified, but the, um, you're right now, it's been a little bit limited in supply for us.

[00:37:32] So, you know, we're, we're. Kind of slowly trickle into them when we can get it. And I, I am so excited by, it's kinda, we have a guy right now, um, myself and my peptides for Brian, who had had a horrible kind of fag nerve damage from, from. Uh, radiation treatment for lymphoma and, you know, and, and, and nothing really would done.

[00:37:53] We'd put them on every peptide we can think of. Really. You know, a lot of you have that Hexham cerebral license and all these neuropeptides, nothing really is touched. I think this [00:38:00] peptide may be the answer for him, you know? So I think that there's gonna be so many people that we can touch with this, but I think you're right.

[00:38:05] It'll be really interesting.

[00:38:07] Carl Lanore: [00:38:07] I'm excited. I actually am. I'm, I'm gonna. Contact and made leader today and, uh, asked my doctor,

[00:38:16] Dr. Elizabeth Yurth, MD: [00:38:16] I'm still waiting to get something.

[00:38:17] Carl Lanore: [00:38:17] Oh, Oh no, no. I mean, if it's that scarce. So, um, can you give me an idea of what a round generally costs a patient?

[00:38:28] Dr. Elizabeth Yurth, MD: [00:38:28] So a four week course has about $1,100.

[00:38:31] So it is not cheap,

[00:38:32] Carl Lanore: [00:38:32] but if you had, but if you have an HSA and you pay with your HSA, you're kind of,

[00:38:38] Dr. Elizabeth Yurth, MD: [00:38:38] all my patients listen. You know, max out your HSA, get a high, high deductible plan, max out your HSA. That's what you're gonna want to use. Nasha, FSA and HSA. Cause that's what you didn't want to be using in medicine.

[00:38:50] Your medical plan is not going to pay for most of the stuff. Quite frankly, that's going to be saving your life to get people out of this insurance-based model where they're [00:39:00] like, Oh, insurance doesn't cover it. I'm not going to do it because the church doesn't cover most of the things they're actually going to cure you.

[00:39:05] Um, this being one of them. Uh, you know, and, and the nice thing about this one, and we have a lot of peptides that are costing people thousand dollars a month. This is about by, but yet it's $1,000 for, but. Once you do that treatment, you've made a huge game that you're going to sustain. So one of the nice things about it, I think is that it, you know, you can do one course and see substantial benefit.

[00:39:26] And like I said, within a few days, substantial benefit. I think it will be interesting to see if, you know, how long are people maintain it? Is it the two to three years that we've, that we've sort of seen or do we retreat. It's the same that I think it was going to be a little, a little bit cost

[00:39:39] Carl Lanore: [00:39:39] prohibitive, but I have an idea for how therapy should be performed for people.

[00:39:46] Well, let's do this. Let's take my last commercial break and when we come back, let's talk about that. Okay? All right. Stay tuned. Superhuman chapel.

[00:40:00] [00:39:59] Welcome

[00:40:00] Dr. Elizabeth Yurth, MD: [00:40:00] back to

[00:40:02] Carl Lanore: [00:40:02] the pep talk here at super human radio.

[00:40:07] Okay, so what if, what if this was a, a type of therapy, right? So you do the four milligrams a day for anywhere from four to eight weeks, uh, to kind of, uh, push the pendulum back as far as you can, while at the same time doing a very thorough, uh, inflammatory marker. A lab work before the, before the therapy.

[00:40:36] So you have a a starting point, and then you can do one through the therapy to make sure that the other things you're doing to compliment the resolution of, and you know, basically you got to extract the insult. You got to look at the person's diet. You've got to look up. All these things. You've got to maybe have them supplement with certain things that we know are good [00:41:00] resolving type things.

[00:41:01] Maybe address some pathways with the re the lab work, but you get, you get them into a place where they're there. They're at an a neutral point where they're not going to damage any more nerves, but they're not going to grow anything. And you introduce a four to eight week therapy and. Watch them thrive and then maybe once they're at that point, you check their inflammatory markers one more time and make sure that things are still where they belong and you send them on their way.

[00:41:30] You say, look, if you keep eating the way you eating, you keep taking your supplements. You, you should, you, you should be right where you are. You're not going to get any worse. But if your lifestyle starts getting wonky again, all bets are off. And then you have them come in once every six months and you say, Hey, how you walk and how you feeling?

[00:41:47] What's going on? Blah, blah, blah, and take some inflammatory markers. Go, okay, you're fine. If not, then they starting to creep up. You put them back on some sort of a prophylactic dose of maybe, you know, I don't know, two milligrams a [00:42:00] day because you don't have that much collateral damage to clean up.

[00:42:04] Dr. Elizabeth Yurth, MD: [00:42:04] Yeah, I'm not sure.

[00:42:05] I mean, I think it's a tough one because you like the time I would get them to this peptide. Usually I've worked them up. I've corrected all their nutrient deficiencies. Normal inflammatory markers. I've kind of done all that, and they're still symptomatic sometimes. I don't know why. Sometimes it's, you can explain it.

[00:42:22] They had chemotherapy, they had some kind of toxic exposure. They have diabetes, diabetes, isn't that, you know, that did the damage and you get the diabetes under better control. The lives of patients are coming in to me and they're, you know, there's director proteins and all their inflammatory markers are not elevated.

[00:42:37] And I'm not really sure why. I mean, I would say that, that you and I right. Okay. What does that do? Why are my feet numb? Why do I have battery notes? I don't really know that, you know, my inflammatory markers are really low. I eat a really clean diet. I take tons of supplements and peptides. I exercise regularly.

[00:42:52] Why? And I think there's people like me and like you. Who am I? I think that I will get great gains out of doing it. I [00:43:00] haven't tried it yet. I think I'll get great gains if you go, we'll do some repair. Now the question is, how long would that maintain? I don't know because I'm not really sure. I think there might be more to the story of why do we have this problem?

[00:43:10] I think as we get into, uh, you know what I told you before, we're working with a company here in Boulder, Colorado called Soma logics. We're measured proteins in blood. Maybe we can get refined this better because maybe you and I have a little bit of some type of abnormal protein, you know, that. That we can epigenetically not modify it.

[00:43:28] I don't know. So I think that there's going to be a group. You're right. We know what's caused it. Yes. We treat the problem with get, you know, and then we do this peptide and then you follow them. And as long as everything stays good, we don't like to retreat up. And that is a group where maybe we're going to have to kind of, you know, retreat periodically.

[00:43:46] I don't know that yet. It'll be interesting to see, and that's going to be sort of self experimentation and experimentation and some of our patients with that. Um, I do hope that as we are able to discern more and more these little proteins that of our blood and say, wow, that [00:44:00] that person who has that re node, they all have this similarity.

[00:44:03] Not there yet, but I think we will be. So I think it's going to be, right now we treat, we see how far we get with it. And we follow. And then maybe we retreat. And you know, and I do the same thing. For instance, treating arthritis in joints with Pettis and poly sulfate. I have a group that I do a six week course.

[00:44:20] They're great. I have a good too. I do six week course and they're great for a little while and they start down slide and I have to treat them again. So I, I think that that we're going to have to sort of play with this a little bit and see what that, what that is not, I'm not sure the consistent dose is realistic either financially or whether how much good it's going to do.

[00:44:36] The two milligrams, at least in the rural studies, didn't show a whole lot of improvement. I think the four milligrams probably going to be the therapeutic dose, but this is one of those things we're going to have to figure out as time goes on. You know, and

[00:44:46] Carl Lanore: [00:44:46] as you

[00:44:47] Dr. Elizabeth Yurth, MD: [00:44:47] know. Sometimes we even use it a long time.

[00:44:49] We still quite know the ideal dosing on. Right,

[00:44:52] Carl Lanore: [00:44:52] right. But at least the nice thing about this is that there was no LD 50 there was nothing like this is, this is like, [00:45:00] it's not like. Oh, if you take too much of this destroying other parts of your body, and you got to limit the therapy, like this does no real harm.

[00:45:09] Dr. Elizabeth Yurth, MD: [00:45:09] It does no harm. And by all accounts, it appears to have other health benefits. Right? So it appears there's nothing but good to come of it. Like repeating doses, I think, except financially, right? That, that there's, there's, there's no longterm benefits. Um, there's a supplement that, that salt Institute has been investigating called J one 47.

[00:45:30] That is a, it's a curcumin like molecule, and that appears to maybe also have some really significant, I'm the mitochondrial function that perhaps has some significant neuro regenerative properties, certainly less expensive. So maybe we find things like that that we can do in between and then do these more powerful things, you know, truly radically through time.

[00:45:50] Carl Lanore: [00:45:50] Well, and let's, let's, let's also throw it might as well throw it in, but if you're raising IGF one, you're raising fibroblast growth factor. Sure, and if you're raising five or less growth factor, [00:46:00] you're, you're creating an environment fertile for new nerves to grow. So obviously you could take this along with the growth hormone secreted Gog

[00:46:08] Dr. Elizabeth Yurth, MD: [00:46:08] In fact, I think you're probably going to do that most of your patients. If I try and you and I, and I think then your retina, maybe once you do the course of the air that you know the  that that then maybe the growth hormone secreted gods have more benefit to you in terms of of the nerve stuff. I, I've been doing this on screen guys for a long time.

[00:46:24] It definitely helped. You haven't cured me. So you know, and are you right? You still have this and your family has some type of Emilio,

[00:46:33] Carl Lanore: [00:46:33] I have the, I have theories. I looked at my sister, uh, and, and I think that, uh, I, I suspect that we have a sensitivity to iron accumulation because all this happened when my sister went through a menopause.

[00:46:48] She stopped menstruating. She always ate steak. Um, I think my symptoms, my father always ate, you know, that side of the family, they always ate beef and red meat. You know, and I, I actually think that [00:47:00] my genes probably want me to be more Mediterranean, like more efficient and, and, and poultry. Um, but I really, you know, the things that could be causing the nerve damage in the first place could be things that drive D myelination, iron drives the myelination.

[00:47:16] Sure. Brian iron is an irritant to nerves. It just irritates him and then blood flow starts to become restricted to them and boom. Now

[00:47:25] Dr. Elizabeth Yurth, MD: [00:47:25] you and I talked about that a lot. And I see patients all the time who are taking iron. I'm like, why are you taking iron? I said, Oh, well, my doctor told me I need an iron.

[00:47:33] I don't need iron. Very few people need iron. Um, you know, so I think that's a huge problem in our society. Everybody, they measure ferritin levels are there at the upper four hundreds. That's not where I want them for longevity. It's not where I want them for girl health or brain health. You know? So I, I, I think that that's.

[00:47:49] That probably is an under looked at thing in terms of people who have neural dysfunction. Uh, you know, but then I think there's the fibromyalgia myalgia crowd. What are they? I think there's something [00:48:00] genetic there. There's probably something out there. Um, and, and like you guys said, I think that right now, I know this'll be a fun peptide to play with, cause I think we can start seeing a lot of these diseases that we're not getting to the bottom of you, you know, um, we may be able to start targeting.

[00:48:17] Looking at them more as neural dysfunction. Then looking at the end organ dysfunction that they create.

[00:48:21] Carl Lanore: [00:48:21] I think, I think that the nervous system is implicated in, in every single disease, including cancer. I mean, it's the nervous system. I, I said it again. It's the electrical system of the body. Without you, you take that one thing away and your heart doesn't function.

[00:48:39] Your organs don't function. Mitochondria don't function. You know, people talk about all the mitochondrial theory of aging. Well, you take the nervous system out and the middle country and that they stopped spinning. They're not spinning anymore. You know,

[00:48:50] Dr. Elizabeth Yurth, MD: [00:48:50] you're right. You're right. And unfortunate what's happened in medicine, we're also subdivided.

[00:48:54] You know how you only look at kidney and you only look at the knee and you know, until we're also divided, then. [00:49:00] And you know, who do you have like looking at the nurses? We have the neurologist, but they're really interested in Parkinson's, ms and you know, and those diseases in the peripheral, you said a peripheral neuropathy patient to the neurologist.

[00:49:12] They do a very basic workup and they go, yeah, most of these are idiopathic, meaning we have no idea what causes them. And you know, good luck. So, you know, we don't really have anybody who's looking at this and this kind of depth. Um, and that's it. That's going to be, you know, time and, you know, and, and people searching out the doctors who will, you know, work with them on this stuff and encourage, you know, you guys out there who have this kind of stuff to find doctors who, who are more progressive, listened to, you know, listen to Carl.

[00:49:36] He, he talks to these people. He knows that people out there who are doing this. He was happy to answer your questions, but. I think that, you know, you know, at boy longevity Institute, we try and pride ourselves on saying, listen, we are keeping abreast of this stuff mean these peptides are coming. You know?

[00:49:50] Right. There's stuff that's really new and unless you're at these conferences, unless you're getting on international pipeline society and reading every day and [00:50:00] looking at this stuff, you don't, you don't know what's out there. You don't know how to help your patients. So you've got to find a doctor, you've got to seek out.

[00:50:07] Well for your, or find information yourself, the final, he's going to work with you. I mean, I think your doctor should be a team with you and you, you know, and be willing to work with you on this.

[00:50:14] Carl Lanore: [00:50:14] So could you, can you work, do you work with people remotely? Uh, dr 

[00:50:18] Dr. Elizabeth Yurth, MD: [00:50:18] and I'm licensed in about three different States, so we have tons of clients out of state.

[00:50:23] So, you know, basically we just zoom conference just like this. We sit there and talk, uh, you know, we sit down and people just like we do here, any office. No, we worked them up and they haven't been worked up. But our goal is to really work with our clients. We're not going to sit and yeah, that's stupid.

[00:50:36] You know that you're not going to give you error to 90 cause you know, we know nothing about it. And I'm so frustrated. You know that. That's why my assists in 30 States is because you really can't find a lot of people. There's you, as you know, a handful of doctors who are learning this stuff and who are keeping abreast of it.

[00:50:51] And the. You know, the podcast on pads, cut ties that are out there, aren't they deep diving into things very well? I think that they're, you know, they're, they, you know, and that needs to be done too. I'm [00:51:00] not going to downplay that. I love that, that people are talking and love, you know, that we're getting this information out there, but we need to also have people understand that there's some really cool stuff that you know, that you need to understand exactly how to use it.

[00:51:12] That's available. And then like this, like thinking outside the box on these diseases like fibromyalgia that you just found this article five miles is probably a small fiber neuropathy novel way. How many people listen to this pocket? So like, geez, never

[00:51:28] Carl Lanore: [00:51:28] get it because, because they're being told by their doctor, Cymbalta, Gabapentin, that be talk, tell them to use.

[00:51:34] Uh, drugs that be fuddled the brain. So you just ignore the pain more. The pain doesn't go away. It's like, it feels so sick that the pain is the least of your worry. That's a horrible way to treat people. I'm sorry. It's not, it's not nice. And you know, there's a lot of doctors out there who one day they develop a disorder and they go, wow.

[00:51:55] Like this is how we, this is how we treat patients. This is how they feel that that's the [00:52:00] moment that they go. There's gotta be a better way. I know a lot of doctors. Who cured their own disorders and ended up changing medicine, uh, because they,

[00:52:13] Dr. Elizabeth Yurth, MD: [00:52:13] because they finally realize what people are going

[00:52:15] Carl Lanore: [00:52:15] through.

[00:52:15] Yes, yes.

[00:52:17] Dr. Elizabeth Yurth, MD: [00:52:17] You know, this stuff, you know, you're, you're really, you really right. That you're actually what got me into a lot of, you know, I, I, I. I've been doing this kind of method now for 17 years. But really what got me into is I developed an autoimmune disease. It was, I don't mean liver disease. My liver started to do this function.

[00:52:32] I was like, you don't need a liver transplant. And nothing traditional medicine was doing. So I started getting into learning about all these other things that you can do, and you know, I'm true to myself, and that's what really got me into it. So I do think you're right from personal approach. A lot of us get into this because, because we sort of look at.

[00:52:47] Wow. You

[00:52:47] Carl Lanore: [00:52:47] know, regular medicine. You'll look at it. Look at Dr. Terry Walls. She was a professor in university. She was in private practice. She developed ms. she went from walking and riding her [00:53:00] bicycle around campus to having to have people push her in a wheelchair. And she did a deep dive and came up with what is basically the walls protocol.

[00:53:09] And. She's back to walking and riding her bike again. Now, if she would've just let herself be treated the way medicine was doing it, at that point in time, she would have ended up on a bunch of drugs and she'd probably be dead today. Because once you can, once you become prisoner in your body, you, you have no, there's no hope.

[00:53:25] You lose hope entirely. But her approach to fixing, and this is an interesting one to her approach to fixing. Her disease. Ms is virtually almost the same exact approach that dr Del Bredesen uses to reverse all timers. They don't know each other. They didn't work together, but they both arrived at this whole  and it's a lifestyle.

[00:53:51] It's sleep, it's hormones. It's all these things that we talk about. We've been talking about on the show for 14 frigging years now.

[00:54:00] [00:53:59] Dr. Elizabeth Yurth, MD: [00:53:59] Right? And you got to fix all that stuff, right? But you can fix all that stuff and still have issues. And I, and that's a huge frustration because you know, when you, when you are, when you're living your life, but he's kind of, okay, I'm doing everything right.

[00:54:11] I'm doing this and why am I not getting better? And so you and then people and people get your patients gets so frustrated too because the doctors just don't believe that they're not doing the things that maybe would make them better. Right. I have people who. Yeah. The doctors don't believe that they're eating right.

[00:54:27] You know, and it's not their issue that they are. And so you get these  patients and then, you know, the doctors told anybody about exercise. They said, I am the ducks. Like right. You're not right. So here we have something now where we can, you know, and that's what peptides are gonna allow us to do with everything.

[00:54:43] Eventually. We just have to stay abreast. And how people, you don't have pharmacies like TaylorMade, they're really willing to put themselves out there and, and look at these new things and develop them and not, you know, hopefully we'll be able to keep doing this for almost every disease. This is going to be fun.

[00:54:57] Carl Lanore: [00:54:57] So for the women in the audience who have [00:55:00] fibromyalgia, how do you cover Kentucky or by finding trans? Um.

[00:55:06] Dr. Elizabeth Yurth, MD: [00:55:06] I told her get my license. I

[00:55:07] Carl Lanore: [00:55:07] okay. Okay. So for the, for the, for the women in the audience who was suffering for five fibromyalgia, cause I predict that they would be the ones most likely to look into something because they've been told live with it.

[00:55:18] But how do they reach you?

[00:55:20] Dr. Elizabeth Yurth, MD: [00:55:20] So they just get on our website, go to longevity.com all the information is there and they can sign up and request a little 15 minute, you know, conference and you know, and get the information. My staff. Used to this where people, people again, for all of the countries, so it's get on the website, boy, longevity.com and, and fill out a little form or either call you back or, you know, give us a call.

[00:55:42] Uh, and, and like I said, we set up a zoom conference with you just like this. We can. Yeah, the get you peptides, we can actually order the labs you need. We'll work with you and . It's very simple to work. You don't need to be in front of somebody to do this. But I'm a Christian, just not the finality of people are [00:56:00] one group, the peripheral neuropathy people, people with horrible rhinos, people who have horrible back pants.

[00:56:04] I added pain. Uh, I think this is a, I said, this is this, this drug will eventually get to everybody, you know, so that's how I will eventually get there. But who knows when, I mean, it's. It's going to be caught up in the FDA, you know, red tape for a while. And so we, we have this ability to get this and, um, it's, it's going to be something, I think if you have a disease process that right now you're thinking as you listen to you, and I talk her, okay.

[00:56:28] Wow. Maybe this will be something that I can try a six week course

[00:56:33] Carl Lanore: [00:56:33] and you know, it's not going to hurt you to try it. It's, if it doesn't fix you, that was, that wasn't your base problem, but it's, it doesn't, it's not gonna hurt you to try Steve Wolfington. I don't know. I put that at the bottom. It's submit a tide or ARA two 90.

[00:56:47] The ARA is the, uh, the beginning of the, the company that a designer found discovered this. A peptide is a aerium aerium every rare. Erin,

[00:56:59] Dr. Elizabeth Yurth, MD: [00:56:59] that's

[00:57:00] [00:56:59] Carl Lanore: [00:56:59] where the ARA comes from. Um, but anyway, that's the peptide and that's the one to look for. I, I'm, I'm looking to use it because I really believe that it's not only gonna help me with the neuropathy that I have developed, but I got a feeling it's going to upgrade my wire harness completely.

[00:57:18] And I'll go from being an old broken down jalopy, back to a sports car again. No,

[00:57:24] Dr. Elizabeth Yurth, MD: [00:57:24] no. We always experiment ourselves first. Right. And you know, and, and there's very few peptides that I would ever recommend to my patients that I have not tried. And there's a few, but. Yeah, you and I will experiment with this and we'll try it.

[00:57:36] We'll sort of see it and we'll try and second toe this in the second course and we'll see and we'll be able to get you more information. So you and I will revisit me, talk and put a podcast out in another four months and say, Hey, this

[00:57:44] Carl Lanore: [00:57:44] is the report. Uh, dr , thanks so much for making time and coming on the show to talk about this.

[00:57:50] Okay. All right. Thank you. Take care. And this is Friday, which means I am off tomorrow, so we'll see you Monday. We have great, we have a open season on [00:58:00] men next week. I don't remember if it's Monday or Wednesday, but we're going to talk about the dropping testosterone levels in the population today, where it's coming from and why isn't anyone worried about it?

[00:58:13] Uh, it's a very, very important discussion. We'll talk to you Monday. Thanks for listening and watching today. [00:59:00] .